The C-Terminal V5 Domain of Protein Kinase Cα Is Intrinsically Disordered, with Propensity to Associate with a Membrane Mimetic

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Yang, Yuan ^a   Igumenova, Tatyana I ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; ISOPROTEIN; N DODECYLPHOSPHOCHOLINE; PEPTIDYLPROLYL ISOMERASE PIN1; PROLINE; PROTEIN KINASE C ALPHA; THREONINE; UNCLASSIFIED DRUG; DODECYLPHOSPHORYLCHOLINE; HYBRID PROTEIN; MICELLE; PHOSPHORYLCHOLINE; PROTEIN BINDING;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DOWN REGULATION; HYDROPHOBICITY; MEMBRANE BINDING; MICELLE; MUTATION; NONHUMAN; PROPENSITY SCORE; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; ANIMAL; BINDING SITE; CHEMICAL PHENOMENA; CHEMISTRY; GENETICS; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR MIMICRY; MOUSE; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; STEREOISOMERISM;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICE; MICELLES; MOLECULAR DYNAMICS SIMULATION; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHORYLCHOLINE; PROTEIN BINDING; PROTEIN KINASE C-ALPHA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; STEREOISOMERISM;

EID: 84878790142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065699     Document Type: Article

References (59)

1. Steinberg SF, (2008) Structural basis of protein kinase C isoform function. Physiol Rev 88: 1341-1378.
2. Newton AC, (2001) Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101: 2353-2364.
3. Griner EM, Kazanietz MG, (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294.
4. Churchill E, Budas G, Vallcntin A, Koyanag T, Mochly-Rosen D, (2008) PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol 48: 569-599.
5. Geraldes P, King GL, (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106: 1319-1331.
6. Abrial E, Lucas G, Scarna H, Haddjeri N, Lambas-Senas L, (2011) A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance? Mol Neurobiol 44: 407-419.
7. Kheifets V, Mochly-Rosen D, (2007) Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res 55: 467-476.
8. Kim J, Choi YL, Vallentin A, Hunrichs BS, Hellerstein MK, et al. (2008) Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis. Cancer Res 68: 6831-6839.
9. Ferreira JC, Boer BN, Grinberg M, Brum PC, Mochly-Rosen D, (2012) Protein quality control disruption by PKCbetaII in heart failure; rescue by the selective PKCbetaII inhibitor, betaIIV5-3. PLoS One 7: e33175.
10. Ferreira JC, Koyanagi T, Palaniyandi SS, Fajardo G, Churchill EN, et al. (2011) Pharmacological inhibition of betaIIPKC is cardioprotective in late-stage hypertrophy. J Mol Cell Cardiol 51: 980-987.
11. Palaniyandi SS, Ferreira JC, Brum PC, Mochly-Rosen D, (2011) PKCbetaII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses. J Cell Mol Med 15: 1769-1777.
12. Kim J, Thorne SH, Sun L, Huang B, Mochly-Rosen D, (2011) Sustained inhibition of PKCalpha reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model. Oncogene 30: 323-333.
13. Leonard TA, Rozycki B, Saidi LF, Hummer G, Hurley JH, (2011) Crystal structure and allosteric activation of protein kinase C betaII. Cell 144: 55-66.
14. Takimura T, Kamata K, Fukasawa K, Ohsawa H, Komatani H, et al. (2010) Structures of the PKC-iota kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding. Acta Crystallogr D Biol Crystallogr 66: 577-583.
15. Grodsky N, Li Y, Bouzida D, Love R, Jensen J, et al. (2006) Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor. Biochemistry 45: 13970-13981.
16. Kazanietz MG, Lemmon MA, (2011) Protein kinase C regulation: C1 meets C-tail. Structure 19: 144-146.
17. Stensman H, Larsson C, (2007) Identification of acidic amino acid residues in the protein kinase C alpha V5 domain that contribute to its insensitivity to diacylglycerol. J Biol Chem 282: 28627-28638.
18. Solodukhin AS, Kretsinger RH, Sando JJ, (2007) Initial three-dimensional reconstructions of protein kinase C delta from two-dimensional crystals on lipid monolayers. Cell Signal 19: 2035-2045.
19. Stebbins EG, Mochly-Rosen D, (2001) Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. J Biol Chem. 276: 29644-29650.
20. Sonnenburg ED, Gao T, Newton AC, (2001) The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem 276: 45289-45297.
21. Newton AC, (2003) Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361-371.
22. Gao T, Toker A, Newton AC, (2001) The carboxyl terminus of protein kinase C provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK-1. J Biol Chem 276: 19588-19596.
23. Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27: 1932-1943.
24. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL, (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J 27: 1919-1931.
25. Behn-Krappa A, Newton AC, (1999) The hydrophobic phosphorylation motif of conventional protein kinase C is regulated by autophosphorylation. Curr Biol 9: 728-737.
26. Messerschmidt A, Macieira S, Velarde M, Badeker M, Benda C, et al. (2005) Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif. J Mol Biol 352: 918-931.
27. Xu ZB, Chaudhary D, Olland S, Wolfrom S, Czerwinski R, et al. (2004) Catalytic domain crystal structure of protein kinase C-theta (PKCtheta). J Biol Chem 279: 50401-50409.
28. Wagner J, von Matt P, Sedrani R, Albert R, Cooke N, et al. (2009) Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes. J Med Chem 52: 6193-6196.
29. Marley J, Lu M, Bracken C, (2001) A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20: 71-75.
30. Muhandiram DR, Kay LE, (1994) Gradient-enhanced triple-resonance 3-dimensional NMR experiments with improved sensitivity. J Magn Reson, Ser B 103: 203-216.
31. Kay LE, Xu GY, Yamazaki T, (1994) Enhanced-sensitivity triple-resonance spectroscopy with minimal H2O saturation. J Magn Reson, Ser A 109: 129-133.
32. Clubb RT, Thanabal V, Wagner G, (1992) A constant-time 3-dimensional triple-resonance pulse scheme to correlate intraresidue H-1(N), N-15, and C-13(′) chemical-shifts in N-15-C-13-labeled proteins. J Magn Reson 97: 213-217.
33. Grzesiek S, Anglister J, Bax A, (1993) Correlation of backbone amide and aliphatic side-chain resonances in C-13/N-15-enriched proteins by isotropic mixing of C-13 magnetization. J Magn Reson, Ser B 101: 114-119.
34. Schumann FH, Riepl H, Maurer T, Gronwald W, Neidig KP, et al. (2007) Combined chemical shift changes and amino acid specific chemical shift mapping of protein-protein interactions. J Biomol NMR 39: 275-289.
35. Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, et al. (1994) Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33: 5984-6003.
36. Farrow NA, Zhang O, Forman-Kay JD, Kay LE, (1995) Comparison of the backbone dynamics of a folded and an unfolded SH3 domain existing in equilibrium in aqueous buffer. Biochemistry 34: 868-878.
37. Farrow NA, Zhang O, Szabo A, Torchia DA, Kay LE, (1995) Spectral density function mapping using 15N relaxation data exclusively. J Biomol NMR 6: 153-162.
38. Peng JW, Wagner G, (1992) Mapping of the spectral densities of N-H bond motions in eglin c using heteronuclear relaxation experiments. Biochemistry 31: 8571-8586.
39. Peng JW, Wagner G, (1992) Mapping of spectral density functions using heteronuclear NMR relaxation measurements. J Magn Reson 98: 308-332.
40. Kuliopulos A, Walsh CT, (1994) Production, purification, and cleavage of tandem repeats of recombinant peptides. J Am Chem Soc 116: 4599-4607.
41. Bornancin F, Parker PJ, (1997) Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J Biol Chem 272: 3544-3549.
42. Bornancin F, Parker PJ, (1996) Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Calpha. Curr Biol 6: 1114-1123.
43. Edwards AS, Faux MC, Scott JD, Newton AC, (1999) Carboxyl-terminal phosphorylation regulates the function and subcellular localization of protein kinase C betaII. J Biol Chem 274: 6461-6468.
44. Edwards AS, Newton AC, (1997) Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C. J Biol Chem. 272: 18382-18390.
45. Uversky VN, Li J, Souillac P, Millett IS, Doniach S, et al. (2002) Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 277: 11970-11978.
46. Greenfield NJ, (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1: 2876-2890.
47. Provencher SW, Glockner J, (1981) Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20: 33-37.
48. Dyson HJ, Wright PE, (2004) Unfolded proteins and protein folding studied by NMR. Chem Rev 104: 3607-3622.
49. Marsh JA, Singh VK, Jia Z, Forman-Kay JD, (2006) Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci 15: 2795-2804.
50. Wright PE, Dyson HJ, (2009) Linking folding and binding. Curr Opin Struct Biol 19: 31-38.
51. Bai Y, Chung J, Dyson HJ, Wright PE, (2001) Structural and dynamic characterization of an unfolded state of poplar apo-plastocyanin formed under nondenaturing conditions. Protein Sci 10: 1056-1066.
52. Jarymowycz VA, Stone MJ, (2006) Fast time scale dynamics of protein backbones: NMR relaxation methods, applications, and functional consequences. Chem Rev 106: 1624-1671.
53. Schubert M, Labudde D, Oschkinat H, Schmieder P, (2002) A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on C-13 chemical shift statistics. J Biomol NMR 24: 149-154.
54. Reimer U, Scherer G, Drewello M, Kruber S, Schutkowski M, et al. (1998) Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J Mol Biol 279: 449-460.
55. Schutkowski M, Bernhardt A, Zhou XZ, Shen M, Reimer U, et al. (1998) Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry 37: 5566-5575.
56. Abrahamsen H, O'Neill AK, Kannan N, Kruse N, Taylor SS, et al. (2012) Peptidyl-prolyl isomerase Pin1 controls down-regulation of conventional protein kinase C isozymes. J Biol Chem 287: 13262-13278.
57. Stewart MD, Morgan B, Massi F, Igumenova TI, (2011) Probing the determinants of diacylglycerol binding affinity in the C1B domain of protein kinase Calpha. J Mol Biol 408: 949-970.
58. Mosior M, McLaughlin S, (1991) Peptides that mimic the pseudosubstrate region of protein kinase C bind to acidic lipids in membranes. Biophys J 60: 149-159.
59. House C, Kemp BE, (1987) Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238: 1726-1728.